Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Fortrea displays strong operational momentum with raised revenue and backlog, cost savings, debt reductions, and a significant 50% rally in 3 weeks; however, margin compression, leverage, legal risk, and overextension temper conviction, requiring active risk management.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Quarterly Improvement ⢠Weak Liquidity ⢠High Leverage FTRE's improving quarterly operations and positive free cash flow are encouraging, but weak liquidity, heavy leverage, and inadequate interest coverage keep the risk profile elevated.
Price Behavior
Key Price Behavior Insights: ⢠Strong September rally ⢠Near-term pullback ⢠Breakout resistance Support Level: $18.80â$19.00 Resistance Level: $20.28â$20.40 FTRE gained 9.6% over the last month, but after pulling back from $20.28, traders should watch $18.80â$19.00 support and a breakout above $20.28â$20.40.
Sentiment & News
Key News Insights: ⢠EBITDA Expansion ⢠Early-Phase Acquisition ⢠Revenue Conversion Fortrea's margin recovery and early-phase acquisition signal improving profitability and growth potential, though sustained revenue conversion remains the key execution risk.
AI Summary
FTRE is a leveraged turnaroundânot a cheap growth storyâwhere the upside depends on bookings converting into sustained organic revenue and operating income rising comfortably above interest expense; investors should remain cautious until free cash flow visibly reduces debt and validates the cost-led recovery.
Description
Fortrea Holdings Inc. is a contract research organization that provides development services for biopharmaceuticals and medical devices globally. Its operations are organized into Clinical Services, covering clinical pharmacology and the spectrum of clinical development, and Enabling Services, which supplies patient access, trial technology, randomization and drug supply support. The company delivers these capabilities through full-service, functional service provider and hybrid models and also offers phase IâIV trial management and post-approval support; it was incorporated in 2023 and is based in Durham, North Carolina.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Dec 4 | Dec 11 | FTRE | Fortrea Holdings Inc. | Fortrea displays strong operational momentum with raised revenue and backlog, cost savings, debt reductions, and a significant 50% rally in 3 weeks; however, margin compression, leverage, legal risk, and overextension temper conviction, requiring active risk management. | Closed | +7.2% |